Pharmacological Management of Dyslipidemia in Atherosclerosis: Limitations, Challenges, and New Therapeutic Opportunities

Kyriakos E. Kypreos,Rafael Bitzur,Eleni A. Karavia,Eva Xepapadaki,George Panayiotakopoulos,Caterina Constantinou

Pharmacological Management of Dyslipidemia in Atherosclerosis: Limitations, Challenges, and New Therapeutic Opportunities

2019

Kyriakos E. Kypreos
Rafael Bitzur
Eleni A. Karavia
Eva Xepapadaki
George Panayiotakopoulos
Caterina Constantinou

Clinical and epidemiological studies during the last 7 decades indicated that elevated low-density lipoprotein cholesterol (LDL-C) levels and reduced high-density lipoprotein cholesterol (HDL-C) le...

Keywords:

Internal medicine
Cardiology
Medicine
Dyslipidemia
Pharmacology
Bioinformatics
pharmacological management
lipoprotein cholesterol
Diabetes mellitus
Epidemiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

102

References

Citations